Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Aroa Biosurgery

US

Last updated May 24, 2026

Part of Aroa Biosurgery Ltd.

Information

Country
US
Address
—
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
—
DUNS Number
—

Catalogue (146)

Page 2 of 3
DeviceModel / ReferenceRegistriesClassStatus
Ovitex® PRS R20253-1122G
FDA UDI
Class IIUnknown
Myriad Morcells™ PW01NA0200
FDA UDI
UActive
Myriad Meshed Expandable Bioscaffold MS01FV1822
FDA UDI
UActive
Ovitex® PRS R30353-1622G
FDA UDI
Class IIUnknown
Endoform Myriad MR05LG1010
FDA UDI
Class IIUnknown
Ovitex® PRS R20343-2022P
FDA UDI
Class IIUnknown
Ovitex® PRS R20353-1622G
FDA UDI
Class IIUnknown
Endoform Antimicrobial Dermal Template 629313
FDA UDI
UActive
Endoform™ Natural Restorative Bioscaffold 529315
FDA UDI
UActive
Myriad Morcells™ PW02NA0050
FDA UDI
UActive
Ovitex® PRS R30353-2022G
FDA UDI
Class IIUnknown
Restella R20253-1020G
FDA UDI
Class IIUnknown
Endoform Natural Dermal Template 529304
FDA UDI
UActive
Ovitex® PRS R20353-2025G
FDA UDI
Class IIUnknown
Restella R20143-1620P
FDA UDI
Class IIUnknown
Endoform Surface SR05LG1010
FDA UDI
UUnknown
Endoform™ Natural Restorative Bioscaffold 529314
FDA UDI
UActive
Ovitex® PRS R20253-0717G
FDA UDI
Class IIUnknown
Myriad Ultra™ Reinforced BioScaffold – Permanent (PP) LP04PP1525
FDA UDI
Class IIUnknown
Restella R20253-1122G
FDA UDI
Class IIUnknown
Endoform Antimicrobial Dermal Template 629314
FDA UDI
UActive
Ovitex® PRS R20143-2020P
FDA UDI
Class IIUnknown
Ovitex® PRS R20143-0416P
FDA UDI
Class IIUnknown
Endoform Surface SR03LG1020
FDA UDI
Class IIUnknown
OviTex® IHR F10243-1317I
FDA UDI
Class IIActive
Myriad Matrix™ Soft Tissue Bioscaffold SR05LG2020US
FDA UDI
UActive
Myriad Matrix™ Soft Tissue Bioscaffold SR03LG0505US
FDA UDI
UActive
Restella R20143-0820P
FDA UDI
Class IIUnknown
Endoform Natural Dermal Template 529316
FDA UDI
UActive
Restella R20343-1622P
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR02LG1020US
FDA UDI
UActive
Restella R20153-1620G
FDA UDI
Class IIUnknown
Endoform™ Natural Restorative Bioscaffold 529302
FDA UDI
UActive
Ovitex® PRS R20153-0416G
FDA UDI
Class IIUnknown
Endoform Antimicrobial Dermal Template 629315
FDA UDI
UActive
Myriad Matrix™ Soft Tissue Bioscaffold SR02LG2020US
FDA UDI
UActive
Restella R20253-1018G
FDA UDI
Class IIUnknown
Endoform™ Natural Restorative Bioscaffold 529316
FDA UDI
UActive
Ovitex® PRS R20153-2020G
FDA UDI
Class IIUnknown
Restella R20243-1020P
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR03LG0710US
FDA UDI
UActive
Ovitex® PRS R20243-1018P
FDA UDI
Class IIUnknown
Endoform™ Natural Restorative Bioscaffold 529311
FDA UDI
UActive
Restella R20243-0815P
FDA UDI
Class IIUnknown
Myriad Meshed Expandable Bioscaffold MS01FH1822
FDA UDI
UActive
Symphony™ Proliferative Bioscaffold CM04HA0505
FDA UDI
UActive
Myriad Matrix™ Soft Tissue Bioscaffold SR02LG0505US
FDA UDI
UActive
Restella R30343-2022P
FDA UDI
Class IIUnknown
Myriad Matrix™ Soft Tissue Bioscaffold SR03LG1020US
FDA UDI
UActive
Restella R20153-0820G
FDA UDI
Class IIUnknown

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (21)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

DateRecall No.ClassStatusReason
Apr 6, 2018Z-0417-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0429-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0419-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0422-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0420-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0433-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0415-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0431-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0423-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0421-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0425-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0428-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0432-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0426-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0416-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0434-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0418-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0427-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0435-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0424-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.

Apr 6, 2018Z-0430-2019—terminated

Degradation of the PGA suture material used in the manufacture of the resorbable mesh devices was observed during an on-going product stability study. Further investigation indicated that devices over 18-months showed evidence of no longer meeting the pre-defined ball burst specification respective to the number of tissue layers.